Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Darin Lippoldt. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Darin Lippoldt har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:NBIX / Neurocrine Biosciences, Inc. | Chief Legal Officer | 43 405 |
US:VOLC / Volcano Corp | EVP, General Counsel | 4 795 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Darin Lippoldt. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Darin Lippoldt som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-14 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 086 | 43 405 | −2,44 | 116,75 | −126 790 | 5 067 512 |
2025-02-14 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 2 017 | 44 491 | 4,75 | ||||
2025-02-14 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 098 | 42 474 | −2,52 | 116,76 | −128 202 | 4 959 264 |
2025-02-14 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 2 083 | 43 572 | 5,02 | ||||
2025-02-14 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
G - Gift | −190 | 41 489 | −0,46 | ||||
2025-02-12 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −911 | 41 679 | −2,14 | 118,25 | −107 727 | 4 928 600 |
2025-02-12 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 1 727 | 42 590 | 4,23 | ||||
2025-02-04 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 250 | 40 863 | −2,97 | 152,91 | −191 133 | 6 248 214 |
2025-02-04 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 2 373 | 42 113 | 5,97 | ||||
2024-08-05 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −2 996 | 39 740 | −7,01 | 154,01 | −461 423 | 6 120 477 |
2024-08-05 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 2 996 | 42 736 | 7,54 | 79,02 | 236 744 | 3 376 999 | |
2024-07-18 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −7 004 | 39 740 | −14,98 | 150,00 | −1 050 590 | 5 960 944 |
2024-07-18 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 7 004 | 46 744 | 17,62 | 79,02 | 553 456 | 3 693 711 | |
2024-02-15 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 098 | 39 740 | −2,69 | 132,99 | −146 028 | 5 285 217 |
2024-02-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −911 | 38 755 | −2,30 | 134,24 | −122 289 | 5 202 312 |
2024-02-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 041 | 37 939 | −2,67 | 142,17 | −147 995 | 5 393 647 |
2024-02-02 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 250 | 37 005 | −3,27 | 140,65 | −175 810 | 5 204 672 |
2024-01-24 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −10 000 | 35 882 | −21,80 | 139,86 | −1 398 553 | 5 018 288 |
2024-01-24 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 10 000 | 45 882 | 27,87 | 79,02 | 790 200 | 3 625 596 | |
2023-12-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −20 830 | 35 882 | −36,73 | 119,86 | −2 496 648 | 4 300 756 |
2023-12-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 20 830 | 56 712 | 58,05 | 43,24 | 900 689 | 2 452 227 | |
2023-11-29 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −10 919 | 35 882 | −23,33 | 112,27 | −1 225 911 | 4 028 587 |
2023-09-01 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
G - Gift | −190 | 46 801 | −0,40 | ||||
2023-08-23 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −2 132 | 46 991 | −4,34 | 107,39 | −228 951 | 5 046 270 |
2023-02-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −911 | 44 973 | −1,99 | 104,08 | −94 815 | 4 680 695 |
2023-02-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −12 801 | 44 157 | −22,47 | 102,42 | −1 311 067 | 4 522 520 |
2023-02-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 522 | 32 660 | −4,45 | 102,24 | −155 613 | 3 339 247 |
2023-02-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 041 | 31 290 | −3,22 | 105,80 | −110 141 | 3 310 592 |
2023-02-02 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 250 | 30 357 | −3,95 | 109,97 | −137 464 | 3 338 396 |
2022-11-10 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −5 082 | 29 234 | −14,81 | 125,04 | −635 442 | 3 655 352 |
2022-11-10 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 5 082 | 34 316 | 17,38 | 43,24 | 219 746 | 1 483 824 | |
2022-11-04 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −4 518 | 29 234 | −13,39 | 125,02 | −564 851 | 3 654 905 |
2022-11-04 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 4 518 | 33 752 | 15,45 | 43,24 | 195 358 | 1 459 436 | |
2022-11-02 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −400 | 29 234 | −1,35 | 125,00 | −50 000 | 3 654 250 |
2022-11-02 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 400 | 29 634 | 1,37 | 43,24 | 17 296 | 1 281 374 | |
2022-11-02 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −10 000 | 29 234 | −25,49 | 120,09 | −1 200 899 | 3 510 708 |
2022-11-02 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 10 000 | 39 234 | 34,21 | 43,24 | 432 400 | 1 696 478 | |
2022-10-28 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −4 923 | 29 234 | −14,41 | 115,04 | −566 332 | 3 363 018 |
2022-10-28 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 4 923 | 34 157 | 16,84 | 43,24 | 212 871 | 1 476 949 | |
2022-10-28 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −5 077 | 29 234 | −14,80 | 115,02 | −583 966 | 3 362 547 |
2022-10-28 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 5 077 | 34 311 | 17,37 | 43,24 | 219 529 | 1 483 608 | |
2022-10-05 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −10 000 | 29 234 | −25,49 | 111,04 | −1 110 446 | 3 246 278 |
2022-10-05 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 10 000 | 39 234 | 34,21 | 43,24 | 432 400 | 1 696 478 | |
2022-09-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
G - Gift | −100 | 29 234 | −0,34 | ||||
2022-09-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
G - Gift | −100 | 29 334 | −0,34 | ||||
2022-03-22 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −8 455 | 29 396 | −22,34 | 95,05 | −803 656 | 2 794 119 |
2022-03-22 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −300 | 37 851 | −0,79 | 95,00 | −28 500 | 3 595 845 |
2022-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −911 | 38 112 | −2,33 | 79,51 | −72 435 | 3 030 323 |
2022-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 041 | 37 296 | −2,72 | 80,74 | −84 048 | 3 011 212 |
2022-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 522 | 36 363 | −4,02 | 80,78 | −122 947 | 2 937 410 |
2022-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −605 | 34 993 | −1,70 | 80,54 | −48 729 | 2 818 490 |
2022-02-02 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit |
A - Award | 9 492 | 9 492 | |||||
2022-02-02 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
A - Award | 64 638 | 64 638 | |||||
2021-12-14 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
G - Gift | −120 | 34 448 | −0,35 | ||||
2021-03-29 |
|
4/A | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
A - Award | 45 546 | 45 546 | |||||
2021-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −36 194 | 0 | −100,00 | 35,99 | −1 302 622 | ||
2021-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −6 008 | 34 361 | −14,88 | 116,21 | −698 160 | 3 992 923 |
2021-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 6 008 | 40 369 | 17,48 | 35,99 | 216 228 | 1 452 880 | |
2021-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −186 | 34 361 | −0,54 | 117,55 | −21 864 | 4 039 136 |
2021-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 186 | 34 547 | 0,54 | 35,99 | 6 694 | 1 243 347 | |
2021-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −30 000 | 34 361 | −46,61 | 116,16 | −3 484 806 | 3 991 381 |
2021-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 30 000 | 64 361 | 87,31 | 35,99 | 1 079 700 | 2 316 352 | |
2021-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit |
A - Award | 6 908 | 6 908 | |||||
2021-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
A - Award | 41 444 | 41 444 | |||||
2021-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 522 | 34 361 | −4,24 | 116,72 | −177 650 | 4 010 654 |
2021-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 198 | 32 991 | −3,50 | 116,74 | −139 859 | 3 851 488 |
2021-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −687 | 31 914 | −2,11 | 116,69 | −80 166 | 3 724 038 |
2021-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −605 | 30 627 | −1,94 | 114,05 | −69 003 | 3 493 129 |
2020-11-16 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −2 257 | 30 082 | −6,98 | 90,72 | −204 755 | 2 729 033 |
2020-08-07 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | −2 257 | 28 051 | −7,45 | 118,87 | −268 297 | 3 334 518 | |
2020-07-10 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −1 657 | 36 194 | −4,38 | 35,99 | −59 635 | 1 302 622 | |
2020-07-10 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 657 | 26 021 | −5,99 | 136,02 | −225 386 | 3 539 387 |
2020-07-10 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 1 657 | 27 678 | 6,37 | 35,99 | 59 635 | 996 131 | |
2020-06-25 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Incentive Stock Option |
M - Exercise | −5 000 | 0 | −100,00 | 32,99 | −164 950 | ||
2020-06-25 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −5 000 | 26 021 | −16,12 | 130,00 | −650 000 | 3 382 730 |
2020-06-25 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 5 000 | 31 021 | 19,22 | 32,99 | 164 950 | 1 023 383 | |
2020-05-20 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Incentive Stock Option |
M - Exercise | −5 000 | 5 000 | −50,00 | 32,99 | −164 950 | 164 950 | |
2020-05-20 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −5 000 | 26 021 | −16,12 | 120,00 | −600 000 | 3 122 520 |
2020-05-20 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 5 000 | 31 021 | 19,22 | 32,99 | 164 950 | 1 023 383 | |
2020-04-28 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 934 | 26 021 | −6,92 | 99,49 | −192 416 | 2 588 861 |
2020-02-11 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 522 | 24 124 | −5,93 | 103,32 | −157 247 | 2 492 398 |
2020-02-07 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit |
A - Award | 7 897 | 7 897 | |||||
2020-02-07 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
A - Award | 49 844 | 49 844 | |||||
2020-02-07 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 198 | 22 755 | −5,00 | 101,47 | −121 556 | 2 308 847 |
2020-02-07 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −605 | 21 678 | −2,72 | 103,15 | −62 407 | 2 236 114 |
2020-02-07 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 145 | 21 133 | −5,14 | 102,88 | −117 800 | 2 174 216 |
2019-11-13 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Incentive Stock Option |
M - Exercise | −3 375 | 10 000 | −25,23 | 32,99 | −111 341 | 329 900 | |
2019-11-13 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −6 625 | 0 | −100,00 | 32,99 | −218 559 | ||
2019-11-13 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −3 375 | 20 103 | −14,38 | 110,02 | −371 307 | 2 211 672 |
2019-11-13 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 3 375 | 23 478 | 16,79 | 32,99 | 111 341 | 774 539 | |
2019-11-13 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −6 625 | 20 103 | −24,79 | 110,00 | −728 750 | 2 211 330 |
2019-11-13 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 6 625 | 26 728 | 32,96 | 32,99 | 218 559 | 881 757 | |
2019-09-05 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −6 736 | 6 625 | −50,42 | 32,99 | −222 221 | 218 559 | |
2019-09-05 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −6 736 | 20 103 | −25,10 | 100,00 | −673 600 | 2 010 300 |
2019-09-05 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 6 736 | 26 839 | 33,51 | 32,99 | 222 221 | 885 419 | |
2019-08-27 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −1 600 | 13 361 | −10,69 | 32,99 | −52 784 | 440 779 | |
2019-08-27 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 600 | 19 961 | −7,42 | 100,00 | −160 000 | 1 996 100 |
2019-08-27 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 1 600 | 21 561 | 8,02 | 32,99 | 52 784 | 711 297 | |
2019-08-27 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −1 664 | 14 961 | −10,01 | 32,99 | −54 895 | 493 563 | |
2019-08-27 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 664 | 19 961 | −7,69 | 100,09 | −166 555 | 1 997 958 |
2019-08-27 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 1 664 | 21 625 | 8,34 | 32,99 | 54 895 | 713 409 | |
2019-07-31 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −15 831 | 0 | −100,00 | 18,15 | −287 333 | ||
2019-07-31 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −15 831 | 19 961 | −44,23 | 92,13 | −1 458 569 | 1 839 081 |
2019-07-31 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 15 831 | 35 792 | 79,31 | 18,15 | 287 333 | 649 625 | |
2019-02-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit |
A - Award | 11 567 | 11 567 | |||||
2019-02-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
A - Award | 62 506 | 62 506 | |||||
2019-02-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −791 | 19 646 | −3,87 | 83,52 | −66 063 | 1 640 810 |
2019-02-06 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −470 | 18 162 | −2,52 | 88,11 | −41 409 | 1 600 168 |
2019-02-06 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −755 | 17 482 | −4,14 | 88,08 | −66 501 | 1 539 830 |
2018-03-07 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −1 979 | 15 831 | −11,11 | 18,15 | −35 919 | 287 333 | |
2018-03-07 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 979 | 16 062 | −10,97 | 88,47 | −175 090 | 1 421 066 |
2018-03-07 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 1 979 | 18 041 | 12,32 | 18,15 | 35 919 | 327 444 | |
2018-02-07 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
F - Taxes | −787 | 16 062 | −4,67 | 82,48 | −64 912 | 1 324 794 | |
2018-02-07 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit |
A - Award | 12 250 | 12 250 | |||||
2018-02-07 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit |
A - Award | 4 600 | 4 600 | |||||
2018-02-07 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
A - Award | 26 050 | 26 050 | |||||
2018-02-07 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −1 979 | 17 810 | −10,00 | 18,15 | −35 919 | 323 252 | |
2018-02-07 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | −758 | 14 574 | −4,94 | 83,13 | −63 012 | 1 211 529 | |
2018-02-07 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 979 | 13 157 | −13,07 | 83,11 | −164 482 | 1 093 528 |
2018-02-07 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 1 979 | 15 136 | 15,04 | 18,15 | 35 919 | 274 718 | |
2018-01-04 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −1 979 | 19 789 | −9,09 | 18,15 | −35 919 | 359 170 | |
2018-01-04 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 979 | 13 157 | −13,07 | 79,36 | −157 053 | 1 044 140 |
2018-01-04 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 1 979 | 15 136 | 15,04 | 18,15 | 35 919 | 274 718 | |
2018-01-02 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −15 237 | 21 768 | −41,18 | 18,15 | −276 552 | 395 089 | |
2018-01-02 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −15 237 | 13 157 | −53,66 | 75,00 | −1 142 775 | 986 775 |
2018-01-02 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 15 237 | 28 394 | 115,81 | 18,15 | 276 552 | 515 351 | |
2017-12-11 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −2 955 | 37 005 | −7,39 | 18,15 | −53 633 | 671 641 | |
2017-12-11 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −2 955 | 13 157 | −18,34 | 75,00 | −221 625 | 986 775 |
2017-12-11 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 2 955 | 16 112 | 22,46 | 18,15 | 53 633 | 292 433 | |
2017-12-06 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −6 279 | 39 960 | −13,58 | 18,15 | −113 964 | 725 274 | |
2017-12-06 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −6 279 | 13 157 | −32,31 | 75,04 | −471 160 | 987 267 |
2017-12-06 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 6 279 | 19 436 | 47,72 | 18,15 | 113 964 | 352 763 | |
2017-11-17 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-qualified Stock Option |
M - Exercise | −9 900 | 22 492 | −30,56 | 18,15 | −179 685 | 408 230 | |
2017-11-17 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −9 900 | 13 157 | −42,94 | 73,05 | −723 191 | 961 114 |
2017-11-17 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 9 900 | 23 057 | 75,25 | 18,15 | 179 685 | 418 485 | |
2017-09-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −100 | 56 139 | −0,18 | 18,15 | −1 815 | 1 018 923 | |
2017-09-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −100 | 13 157 | −0,75 | 60,00 | −6 000 | 789 420 |
2017-09-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 100 | 13 257 | 0,76 | 18,15 | 1 815 | 240 615 | |
2017-08-14 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −5 000 | 56 239 | −8,16 | 18,15 | −90 750 | 1 020 738 | |
2017-08-14 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −5 000 | 13 157 | −27,54 | 55,00 | −275 000 | 723 635 |
2017-08-14 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 5 000 | 18 157 | 38,00 | 18,15 | 90 750 | 329 550 | |
2017-05-23 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −10 000 | 61 239 | −14,04 | 18,15 | −181 500 | 1 111 488 | |
2017-05-23 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −10 000 | 13 157 | −43,18 | 53,27 | −532 700 | 700 873 |
2017-05-23 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 10 000 | 23 157 | 76,01 | 18,15 | 181 500 | 420 300 | |
2017-04-13 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −204 | 13 157 | −1,53 | 51,23 | −10 451 | 674 033 |
2017-04-13 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −12 861 | 13 361 | −49,05 | 50,41 | −648 323 | 673 528 |
2017-02-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −132 | 1 222 | −9,75 | 44,62 | −5 890 | 54 526 |
2017-02-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Restricted Stock Option |
A - Award | 9 100 | 9 100 | |||||
2017-02-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
A - Award | 68 400 | 68 400 | |||||
2017-02-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −821 | 0 | −100,00 | 43,13 | −35 410 | |
2016-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit |
A - Award | 20 500 | 20 500 | |||||
2016-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
A - Award | 41 200 | 41 200 | |||||
2016-02-09 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit |
A - Award | 8 700 | 8 700 | |||||
2015-11-10 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
M - Exercise | −23 761 | 71 239 | −25,01 | 18,15 | −431 262 | 1 292 988 | |
2015-11-10 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −23 761 | 0 | −100,00 | 52,92 | −1 257 432 | |
2015-11-10 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 23 761 | 23 761 | 18,15 | 431 262 | 431 262 | ||
2015-02-05 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
A - Award | 30 000 | 30 000 | 32,99 | 989 700 | 989 700 | ||
2015-02-05 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit |
A - Award | 25 000 | 25 000 | |||||
2014-11-04 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
A - Award | 95 000 | 95 000 | |||||
2014-11-04 | 3 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
0 | ||||||||
2014-03-20 |
|
4 | VOLC |
Volcano Corp
Common Stock |
S - Sale | X | −1 377 | 4 795 | −22,31 | 23,03 | −31 711 | 110 424 |
2014-03-03 |
|
4 | VOLC |
Volcano Corp
Common Stock |
S - Sale | X | −535 | 6 172 | −7,98 | 21,72 | −11 620 | 134 056 |
2014-03-03 |
|
4 | VOLC |
Volcano Corp
Restricted Stock Units |
M - Exercise | −1 201 | 2 401 | −33,34 | ||||
2014-03-03 |
|
4 | VOLC |
Volcano Corp
Common Stock |
M - Exercise | 1 201 | 6 304 | 23,54 | ||||
2014-02-21 |
|
4 | VOLC |
Volcano Corp
Common Stock |
S - Sale | X | −504 | 5 103 | −8,99 | 21,86 | −11 017 | 111 552 |
2014-02-21 |
|
4 | VOLC |
Volcano Corp
Restricted Stock Units |
M - Exercise | −1 132 | 3 395 | −25,01 | ||||
2014-02-21 |
|
4 | VOLC |
Volcano Corp
Common Stock |
M - Exercise | 1 132 | 5 607 | 25,30 | ||||
2014-02-19 |
|
4 | VOLC |
Volcano Corp
Common Stock |
S - Sale | X | −310 | 4 475 | −6,48 | 21,36 | −6 622 | 95 586 |
2014-02-19 |
|
4 | VOLC |
Volcano Corp
Restricted Stock Units |
M - Exercise | −700 | 700 | −50,00 | ||||
2014-02-19 |
|
4 | VOLC |
Volcano Corp
Common Stock |
M - Exercise | 700 | 4 785 | 17,14 | ||||
2014-02-19 |
|
4 | VOLC |
Volcano Corp
Common Stock |
S - Sale | X | −307 | 4 085 | −6,99 | 21,36 | −6 558 | 87 256 |
2014-02-14 |
|
4 | VOLC |
Volcano Corp
Restricted Stock Units |
A - Award | 7 483 | 7 483 | |||||
2014-02-14 |
|
4 | VOLC |
Volcano Corp
Performance Shares |
M - Exercise | −694 | 1 387 | −33,35 | ||||
2014-02-14 |
|
4 | VOLC |
Volcano Corp
Performance Shares |
A - Award | 2 081 | 2 081 | |||||
2014-02-14 |
|
4 | VOLC |
Volcano Corp
Common Stock |
M - Exercise | 694 | 4 392 | 18,77 | ||||
2014-01-17 |
|
4 | VOLC |
Volcano Corp
Common Stock |
S - Sale | X | −750 | 3 698 | −16,86 | 21,15 | −15 862 | 78 213 |
2014-01-03 |
|
4 | VOLC |
Volcano Corp
Common Stock |
S - Sale | X | −289 | 4 448 | −6,10 | 21,68 | −6 266 | 96 433 |
2014-01-03 |
|
4 | VOLC |
Volcano Corp
Performance Shares |
M - Exercise | −760 | 760 | −50,00 | ||||
2014-01-03 |
|
4 | VOLC |
Volcano Corp
Common Stock |
M - Exercise | 760 | 4 737 | 19,11 | ||||
2013-04-16 |
|
4/A | VOLC |
Volcano Corp
Restricted Stock Units |
A - Award | 4 527 | 4 527 | |||||
2013-04-16 |
|
4/A | VOLC |
Volcano Corp
Non-Qualified Stock Option (Right to Buy) |
A - Award | 7 522 | 7 522 | |||||
2013-04-16 |
|
4/A | VOLC |
Volcano Corp
Non-Qualified Stock Option (Right to Buy) |
A - Award | 19 885 | 19 885 | |||||
2013-03-01 |
|
4 | VOLC |
Volcano Corp
Restricted Stock Units |
M - Exercise | −1 201 | 3 602 | −25,01 | ||||
2013-03-01 |
|
4 | VOLC |
Volcano Corp
Common Stock |
S - Sale | X | −516 | 3 227 | −13,79 | 21,68 | −11 189 | 69 977 |
2013-03-01 |
|
4 | VOLC |
Volcano Corp
Common Stock |
M - Exercise | 1 201 | 3 743 | 47,25 | ||||
2013-02-22 |
|
4 | VOLC |
Volcano Corp
Common Stock |
S - Sale | X | −345 | 2 542 | −11,95 | 24,67 | −8 512 | 62 715 |
2013-02-22 |
|
4/A | VOLC |
Volcano Corp
Restricted Stock Units |
A - Award | 7 519 | 7 519 | |||||
2013-02-21 |
|
4 | VOLC |
Volcano Corp
Restricted Stock Units |
A - Award | 7 343 | 7 343 | |||||
2013-02-21 |
|
4 | VOLC |
Volcano Corp
Non-Qualified Stock Option (Right to Buy) |
A - Award | 12 493 | 12 493 | |||||
2013-02-21 |
|
4 | VOLC |
Volcano Corp
Performance Shares |
M - Exercise | −760 | 1 520 | −33,33 | ||||
2013-02-21 |
|
4 | VOLC |
Volcano Corp
Performance Shares |
A - Award | 2 280 | 2 280 | |||||
2013-02-21 |
|
4 | VOLC |
Volcano Corp
Common Stock |
M - Exercise | 760 | 2 887 | 35,73 | ||||
2013-02-19 |
|
4 | VOLC |
Volcano Corp
Common Stock |
S - Sale | X | −313 | 2 127 | −12,83 | 25,23 | −7 897 | 53 666 |
2013-02-19 |
|
4 | VOLC |
Volcano Corp
Restricted Stock Units |
M - Exercise | −700 | 1 400 | −33,33 | ||||
2013-02-19 |
|
4 | VOLC |
Volcano Corp
Common Stock |
M - Exercise | 700 | 2 440 | 40,23 | ||||
2012-03-29 |
|
4/A | VOLC |
Volcano Corp
Common Stock |
S - Sale | X | −296 | 1 740 | −14,54 | 28,07 | −8 309 | 48 842 |
2012-03-29 |
|
4/A | VOLC |
Volcano Corp
Restricted Stock Units |
M - Exercise | −700 | 2 100 | −25,00 | ||||
2012-03-29 |
|
4/A | VOLC |
Volcano Corp
Common Stock |
M - Exercise | 700 | 2 036 | 52,40 | ||||
2012-02-29 |
|
4 | VOLC |
Volcano Corp
Restricted Stock Units |
A - Award | 4 803 | 4 803 | |||||
2012-02-29 |
|
4 | VOLC |
Volcano Corp
Employee Stock Option (Right to Buy) |
A - Award | 6 527 | 6 527 | |||||
2012-02-17 |
|
4 | VOLC |
Volcano Corp
Common Stock |
S - Sale | X | −296 | 404 | −42,29 | 28,07 | −8 309 | 11 340 |
2012-02-17 |
|
4 | VOLC |
Volcano Corp
Common Stock |
M - Exercise | 700 | 700 | |||||
2012-02-17 |
|
4 | VOLC |
Volcano Corp
Restricted Stock Units |
M - Exercise | −700 | 2 100 | −25,00 |